Clinical and economic implications of upper gastrointestinal adverse events in Asian rheumatological patients on long-term non-steroidal anti-inflammatory drugs.

@article{Pok2018ClinicalAE,
  title={Clinical and economic implications of upper gastrointestinal adverse events in Asian rheumatological patients on long-term non-steroidal anti-inflammatory drugs.},
  author={Lydia Say Lee Pok and Fatiha Hana Shabaruddin and Maznah Dahlui and Sargunan Sockalingam and Mohd Shahrir Mohamed Said and Azmillah Rosman and Ing Soo Lau and Liza Mohd Isa and Heselynn Hussein and Chin Teck Ng and Sanjiv Mahadeva},
  journal={International journal of rheumatic diseases},
  year={2018},
  volume={21 5},
  pages={
          943-951
        }
}
AIM To determine the incidence and direct costs of NSAID-induced upper GI adverse events in Malaysian rheumatology patients. METHODS A retrospective, multi-centre, cohort study of rheumatology patients on long-term NSAIDs was conducted. Clinical data of patients treated between 2010 and 2013 were collected for a 24-month follow-up period. The costs of managing upper GI adverse events were based on patient level resource use data. RESULTS Six hundred and thirty-four patients met the… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review.

  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2007